Welcome to Our Company
Send Inquiry
Lapatinib 250mg
100 USD ($)/Bottle
Product Details:
- Indication Breast cancer (HER2-positive), in combination with other agents
- Dosage Form Tablet
- Salt Composition Lapatinib Tablets IP 250 mg
- Enzyme Types N/A (Not an enzyme preparation)
- Feature Oral administration, targeted therapy
- Ingredients Each film coated tablet contains Lapatinib Ditosylate Monohydrate equivalent to Lapatinib 250 mg
- Application Antineoplastic/Anti-cancer therapy
- Click to view more
X
Lapatinib 250mg Price And Quantity
- 100 USD ($)/Bottle
- 10 Bottle
Lapatinib 250mg Product Specifications
- Store below 30C, protect from moisture
- Oral administration, targeted therapy
- Each film coated tablet contains Lapatinib Ditosylate Monohydrate equivalent to Lapatinib 250 mg
- Breast cancer (HER2-positive), in combination with other agents
- Yellow, oval-shaped film-coated tablet
- 24 months
- Lapatinib Tablets IP 250 mg
- N/A (Not an enzyme preparation)
- Antineoplastic/Anti-cancer therapy
- Tablet
Lapatinib 250mg Trade Information
- Mumbai International Airport or By sea
- Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Western Union, Paypal, Cash Against Delivery (CAD), Cash Advance (CA), Telegraphic Transfer (T/T), Cash in Advance (CID)
- 500 Bottle Per Week
- 7 Days
- Yes
- Sample costs shipping and taxes has to be paid by the buyer
- Pack of 150 Tablets
- Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Asia, Central America, Africa
- Manipur, Nagaland, Chandigarh, Himachal Pradesh, Pondicherry, Uttarakhand, Daman and Diu, Dadra and Nagar Haveli, Lakshadweep, Gujarat, South India, Central India, North India, East India, Andaman and Nicobar Islands, Andhra Pradesh, Assam, Arunachal Pradesh, Bihar, Delhi, Goa, Jammu and Kashmir, Jharkhand, Karnataka, Kerala, Maharashtra, Mizoram, Meghalaya, Punjab, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, Haryana, West Bengal, Madhya Pradesh, Odisha, West India, Chhattisgarh, Uttar Pradesh, All India
- ISO/GMP/c-GMP/WHOGMP/USFDA/EUP
Product Description
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients. Hetero has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs). The tablets are usPrecision in Breast Cancer Therapy
Lapatinib 250mg targets HER2-positive breast cancer at the molecular level for patients who require advanced therapy. The drug is designed as an oral tablet, offering a convenient and effective alternative to injectable treatments. Used in combination with other agents, it provides a pivotal role in customized oncological regimens that can be managed from home under medical supervision.
High Quality and Safety Standards
Formulated with Lapatinib Ditosylate Monohydrate, this medication upholds stringent quality standards, exceeding 99% purity. Its stability and efficacy are maintained through careful packaging in blister packs or bottles. The product is rigorously tested, ensuring safety and consistency throughout its 24-month shelf life. Always store below 30C to preserve potency and prevent moisture-induced degradation.
FAQs of Lapatinib 250mg:
Q: How should Lapatinib 250mg be administered?
A: Lapatinib 250mg is intended for oral administration. Take the tablet whole, preferably at the same time each day, on an empty stomach or as directed by your healthcare provider. Do not split, crush, or chew the tablet to ensure correct dosing.Q: What is the therapeutic benefit of using Lapatinib 250mg?
A: Lapatinib 250mg is beneficial for patients with HER2-positive breast cancer. When used in combination with other agents, it provides targeted therapy to help inhibit tumor growth and improve treatment outcomes.Q: When should Lapatinib 250mg be used during cancer treatment?
A: This medication is typically prescribed for patients with advanced or metastatic HER2-positive breast cancer, especially when other treatments have proven ineffective or as part of a combination therapy, as advised by an oncologist.Q: Where should I store Lapatinib 250mg tablets?
A: Lapatinib tablets must be stored below 30C and protected from moisture. Keep them in their original blister pack or bottle, away from direct sunlight and out of reach of children.Q: What process ensures the purity and quality of Lapatinib 250mg?
A: Each batch of Lapatinib 250mg undergoes strict quality controls to guarantee a purity greater than 99%. Packaging in blister packs or bottles helps maintain product stability throughout its 24-month shelf life.Q: Is a prescription required for Lapatinib 250mg, and why?
A: Yes, a valid prescription is required. Lapatinib is a potent antineoplastic agent intended for specific cancer types and must be used under medical supervision to manage dosing, monitor side effects, and optimize therapeutic benefits.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicine' category
Send Inquiry
Send SMS
Call Me FreeSLOGEN BIOTECH
GST : 24CGUPA4277R2ZK
GST : 24CGUPA4277R2ZK
- 264, Green Plaza, Second Floor, Golden Chowkadi, Mota Varacha, Surat - 394101, Gujarat, India
- Phone : 08045811974
- Mr Avadh Ambaliya (Proprietor)
- Mobile : 08045811974
-
info@slogenbiotech.com
|
SLOGEN BIOTECH
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
